GlassScriptPhysician profile
Ashish Awasthi
NPI 1033146618
$4,757.97
in general payments reported to CMS, 2019-2025
14 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $14.99 · 2021: $440 · 2022: $602 · 2023: $935 · 2024: $265 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,335.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,431.11 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Mamba |
| Abiomed | $1,060.49 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $907.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $438.60 | 2019-2022 | |
| Irhythm Technologies, INC. | $226.07 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $161.05 | 2019-2021 | |
| Medtronic, INC. | $108.06 | 2022-2024 | Micra |
| Biosense Webster, INC. | $89.42 | 2023 | Qdot Micro Catheter |
| Cardiva Medical, INC. | $89.37 | 2023 | Cardiva Vascade 6/7f Vcs |
| Janssen Pharmaceuticals, INC | $83.64 | 2019-2022 | |
| Novo Nordisk INC | $78.88 | 2024-2025 | Wegovy, Ozempic |
| Cook Medical LLC | $41.70 | 2025 | |
| Avinger INC. | $25.00 | 2019 | |
| Impulse Dynamics (USA) INC. | $17.35 | 2024 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Awasthi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.